Dave Farraday is a clinical research coordinator supporting the Be Active study. The Be Active study is determining the effectiveness of activity monitoring for patients at risk for atherosclerotic cardiovascular disease.
Before joining the team, Dave supported the Clinical Trials Office within the Department of Radiation Oncology for the University of Pennsylvania Health System. Dave provided support for research studies that focused primarily on radiation therapy in the treatment of gastrointestinal and central nervous system cancers. He earned his bachelor of science from Temple University.
